Explore

Companies

Drugs

About·Data Management·Terms·Privacy

Stay informed

© 2026 VivoSeq. All rights reserved.

Oral nicotine pouches

Approved

MMedical University of South Carolina

Oral nicotine pouches is one of 2 therapeutic programs targeting Smoking. It is currently in Approved.

1

Indications

1

Total Trials

1

Active Trials

1

Competitors

Pipeline

Status by Indication[2][1]

Indication

SmokingEnrolling by invitation

SmokingApproved

Enrolling by invitation

Competition

Competitive Landscape

4 competitors in Smoking

#DrugCompanyPhaseTrials

Wellbutrin

GGlaxo Dba Glaxosmithkline

Oral nicotine pouches

MMedical University of South Carolina

Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.

Clinical

Trials by Indication[1]

Smoking1 trial

Piloting Novel Interventional Strategies to Improve Nicotine Pouches as a Substitute for Smoking

Enrolling by invitation·MMedical University of South Carolina·Approved·NCT07625956·10 enrolled

Sources

References

[1]
ClinicalTrials.gov — 1 trial record for Oral nicotine pouches. U.S. National Library of Medicine, National Institutes of Health.
[2]
Open Targets Platform — Drug–disease associations for Oral nicotine pouches. EMBL-EBI & Wellcome Sanger Institute.
[3]
SEC EDGAR — Medical University of South Carolina company filings. U.S. Securities and Exchange Commission.

Details

Drug Info

Quick Facts

Highest Phase: Approved[1]
Company: MMedical University of South Carolina

Related News